TRIANGEL touts dual-wavelength endolaser for facial contouring
TRIANGEL RSD LIMITED is promoting a dual 980nm and 1470nm endolaser platform for facial contouring, collagen stimulation and subdermal fat treatment. The company says the system is built for medical aesthetic clinics, backed by ISO 13485, FDA clearance and CE certification, and used in more than 80 countries.
Why it matters: - TRIANGEL is targeting a common aesthetic-surgery tradeoff: more precise subdermal treatment without the wider tissue disruption of traditional rhytidectomy. - The platform is positioned for clinics that want facial contouring, tissue contraction and collagen remodeling in one device. - The company says the system is designed to improve procurement and service for distributors and private clinics through direct factory support.
What happened: - TRIANGEL RSD LIMITED promoted a dual-wavelength endolaser platform built around 980nm and 1470nm laser modules. - The company says the platform is intended for precision facial contouring, collagen boost and subcutaneous fat treatment. - TRIANGEL published the product description on September 21, 2026, and directed readers to the official medical engineering portal.
The details: - The 1470nm module offers adjustable power from 1 to 17 watts and is described as highly absorbed by interstitial water and intracellular adipocytes. - The 980nm module operates from 1 to 30 watts and is described as aligned with intravascular oxyhemoglobin absorption peaks. - TRIANGEL says the two wavelengths work through a single optical interface to stabilize the treatment field and distribute heat more evenly under the skin. - The system uses American QPC laser diode arrays built on gallium aluminum arsenide substrates, with thermal dissipation assemblies to support longer clinical cases. - TRIANGEL says the platform uses sterile silica fibers with SMA905 connectors. - The fiber range includes 200 to 300 micrometer micro-fibers for delicate facial planes and 400 to 600 micrometer bare-tip and radial-emitting fibers for broader submental and mandibular zones. - The company says standard calibration ports help preserve low transmission loss and consistent energy delivery. - TRIANGEL says controlled heating in the 50 to 65 degrees Celsius range drives septal contraction and fibroblast activity. - The company says adipocyte membranes rupture at 55 degrees Celsius, turning fat into an emulsion for metabolic clearance. - Practitioners can adjust pulse widths from 1 to 10,000 milliseconds and choose continuous wave, pulse or single pulse modes. - The system includes 650nm aiming beams for transillumination and fiber-tip positioning. - TRIANGEL says clinicians can apply 15 to 30 joules per square centimeter for jawline sculpting. - The platform can also integrate 638nm and 658nm low-level photobiomodulation for circulation and healing support.
Between the lines: - TRIANGEL is framing the device as both a clinical tool and a manufacturing platform, with emphasis on energy control, fiber precision and standardized production. - The company is also signaling a commercial strategy built around global distributors, private-label partners and factory-direct customization. - Claimed certifications and installation counts are meant to reduce buyer risk and support international adoption.
What's next: - TRIANGEL says it will continue refining treatment protocols through collaborations with 15 partner hospitals and four European research centers. - The company says it operates two flagship training centers in the U.S. and service branches in Italy and Portugal. - TRIANGEL is inviting clinics, institutes and distributors to request technical specifications, clinical protocol guidance and factory quotations through its website. - The company says worldwide door-to-door delivery can take two weeks.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Portugal News Bulletin
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.